Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Dale

Blood

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Blood|July 2, 2016
Tracers for tracing neutrophilsDavid C Dale
Blood|August 8, 2008
The phagocytes: neutrophils and monocytesDavid C Dale, Laurence Boxer, W Conrad Liles
Blood|June 4, 2011
Deuterium and neutrophil kineticsKelvin W Li, Scott M Turner, Claire L Emson, et al.
Blood|January 18, 2003
Retraction. Neutrophil elastase mutations in severe congenital neutropenia patients of the original Kostmann familyAndrew A Aprikyan, Goran Carlsson, Steve Stein, et al.
Blood|August 13, 2011
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndromeDavid C Dale, Audrey Anna Bolyard, Merideth L Kelley, et al.
Blood|February 7, 2004
Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cellsGöran Carlsson, Andrew A G Aprikyan, Ramin Tehranchi, et al.
Blood|May 17, 2003
Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF deliveryOfer Yanay, Simon C Barry, Louis J Katen, et al.
Blood|July 12, 2003
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistW Conrad Liles, Hal E Broxmeyer, Elin Rodger, et al.
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
Blood|February 25, 2006
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapyPhilip S Rosenberg, Blanche P Alter, Audrey A Bolyard, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Blood|July 2, 2016
Tracers for tracing neutrophilsDavid C Dale
Blood|August 8, 2008
The phagocytes: neutrophils and monocytesDavid C Dale, Laurence Boxer, W Conrad Liles
Blood|June 4, 2011
Deuterium and neutrophil kineticsKelvin W Li, Scott M Turner, Claire L Emson, et al.
Blood|January 18, 2003
Retraction. Neutrophil elastase mutations in severe congenital neutropenia patients of the original Kostmann familyAndrew A Aprikyan, Goran Carlsson, Steve Stein, et al.
Blood|August 13, 2011
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndromeDavid C Dale, Audrey Anna Bolyard, Merideth L Kelley, et al.
Blood|February 7, 2004
Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cellsGöran Carlsson, Andrew A G Aprikyan, Ramin Tehranchi, et al.
Blood|May 17, 2003
Treatment of canine cyclic neutropenia by lentivirus-mediated G-CSF deliveryOfer Yanay, Simon C Barry, Louis J Katen, et al.
Blood|July 12, 2003
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistW Conrad Liles, Hal E Broxmeyer, Elin Rodger, et al.
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
Blood|February 25, 2006
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapyPhilip S Rosenberg, Blanche P Alter, Audrey A Bolyard, et al.
Pageof 2